ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00430846
Recruitment Status : Completed
First Posted : February 2, 2007
Last Update Posted : December 18, 2014
Sponsor:
Information provided by (Responsible Party):
Seattle Genetics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2009
  Actual Study Completion Date : July 2009